ArticleBioengineering (Basel, Switzerland)2025
Segmentation of Brain Tumors Using a Multi-Modal Segment Anything Model (MSAM) with Missing Modality Adaptation.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Review of Deep Learning Approaches Based on Segment Anything Model for Medical Image Segmentation.Bioengineering (Basel, Switzerland) · 2025Review
- A single model for glioblastoma segmentation with and without T2-FLAIR: independent validation of a targeted dropout strategy.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This paper presents a novel multi-modal segment anything model (MSAM) for glioma tumor segmentation using structural MRI images and diffusion tensor imaging data. We designed an effective multimodal feature fusion block to effectively integrate features from different modalities of data, thereby improving the accuracy of brain tumor segmentation. We have designed an effective missing modality training method to address the issue of missing modalities in actual clinical scenarios. To evaluate the effectiveness of MSAM, a series of experiments were conducted comparing its performance with U-Net across various modality combinations. The results demonstrate that MSAM consistently outperforms U-Net in terms of both Dice Similarity Coefficient and 95% Hausdorff Distance, particularly when structural modality data are used alone. Through feature visualization and the use of missing modality training, we show that MSAM can effectively adapt to missing data, providing robust segmentation even when key modalities are absent. Additionally, segmentation accuracy is influenced by tumor region size, with smaller regions presenting more challenges. These findings underscore the potential of MSAM in clinical applications where incomplete data or varying tumor sizes are prevalent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.